NO20042612L - Preparat for potensiering av et opiatanalgetikum og anvendelse derav for behandling av smerte hos et pattedyr. - Google Patents

Preparat for potensiering av et opiatanalgetikum og anvendelse derav for behandling av smerte hos et pattedyr.

Info

Publication number
NO20042612L
NO20042612L NO20042612A NO20042612A NO20042612L NO 20042612 L NO20042612 L NO 20042612L NO 20042612 A NO20042612 A NO 20042612A NO 20042612 A NO20042612 A NO 20042612A NO 20042612 L NO20042612 L NO 20042612L
Authority
NO
Norway
Prior art keywords
potentiating
mammal
preparation
treating pain
opiate analgesic
Prior art date
Application number
NO20042612A
Other languages
English (en)
Norwegian (no)
Inventor
Anil Gulati
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of NO20042612L publication Critical patent/NO20042612L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20042612A 2001-11-27 2004-06-22 Preparat for potensiering av et opiatanalgetikum og anvendelse derav for behandling av smerte hos et pattedyr. NO20042612L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33359901P 2001-11-27 2001-11-27
PCT/US2002/037461 WO2003045434A2 (en) 2001-11-27 2002-11-22 Endothelin antagonists ina method and composition for potentiating an opiate analgesic

Publications (1)

Publication Number Publication Date
NO20042612L true NO20042612L (no) 2004-06-22

Family

ID=23303472

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042612A NO20042612L (no) 2001-11-27 2004-06-22 Preparat for potensiering av et opiatanalgetikum og anvendelse derav for behandling av smerte hos et pattedyr.

Country Status (14)

Country Link
US (3) US7973064B2 (es)
EP (1) EP1448233A2 (es)
JP (1) JP2005513033A (es)
CN (1) CN1646166A (es)
AU (1) AU2002348224A1 (es)
BR (1) BR0214481A (es)
CA (1) CA2464768C (es)
CO (1) CO5590940A2 (es)
EA (1) EA200400734A1 (es)
EC (1) ECSP045153A (es)
MX (1) MXPA04005003A (es)
NO (1) NO20042612L (es)
WO (1) WO2003045434A2 (es)
ZA (1) ZA200403162B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070300258A1 (en) * 2001-01-29 2007-12-27 O'connor Daniel Methods and systems for providing media assets over a network
DE60143671D1 (de) * 2001-06-07 2011-01-27 Sang Christine Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor-antagonists
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US8563592B2 (en) 2001-11-01 2013-10-22 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment and methods
EP2060259B1 (en) 2001-11-01 2010-01-20 Spectrum Pharmaceuticals, Inc. Medical compositions for intravesical treatment of bladder cancer
US7351692B2 (en) 2002-06-19 2008-04-01 The Board Of Trustees Of The University Of Illinois Method and composition for potentiating the antipyretic action of a nonopioid analgesic
GB0219660D0 (en) 2002-08-23 2002-10-02 Astrazeneca Ab Therapeutic use
US8217010B2 (en) 2002-10-24 2012-07-10 The Board Of Trustees Of The University Of Illinois Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
US20070032422A1 (en) 2002-10-24 2007-02-08 Spectrum Pharmaceuticals, Inc. Methods, compositions and articles of manufacture for contributing to the treatment of cancers
CN1729012B (zh) 2002-10-24 2013-05-22 伊利诺伊大学评议会 治疗实体瘤的组合物
US8026216B2 (en) 2002-10-24 2011-09-27 Spectrum Pharmaceuticals, Inc. Methods and compositions for contributing to the treatment of cancers
GB0403744D0 (en) 2004-02-20 2004-03-24 Astrazeneca Ab Chemical process
EP1976549A4 (en) * 2005-09-09 2010-05-19 Chicago Labs Inc ENDOTHELIN RECEPTORS FOR WEANING MORPHINE
EP2314289A1 (en) * 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
ES2541657T3 (es) 2006-08-31 2015-07-23 Spectrum Pharmaceuticals, Inc. Sensibilización de células tumorales a terapia de radiación a través de la administración de agonistas de endotelina
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
WO2009015917A2 (en) * 2007-05-14 2009-02-05 F. Hoffmann-La Roche Ag Dihydroquinone and dihydronaphthridine inhibitors of jnk
US20090143426A1 (en) * 2007-12-04 2009-06-04 Ralph Anthony Stephani Synthesis of 1,3,6-trisubstituted-2-carboxyquinol-4-ones as selective ET A antagonists and their use as medicaments
PL2424529T3 (pl) * 2009-04-30 2017-06-30 Midwestern University Nowe postępowania terapeutyczne z zastosowaniem centakwiny
US9308235B2 (en) 2012-05-09 2016-04-12 Spectrum Pharmaceuticals, Inc. Treatment of primary and metastatic carcinoma
EP3019242B1 (en) 2013-07-08 2020-08-19 Midwestern University Compositions and methods for treating neuropsychiatric disorders using an endothelin-b receptor agonist
CN112469474A (zh) 2018-05-03 2021-03-09 美国中西部大学 出血和centhaquin引起的复苏后内皮素受体的变化
CN112569238A (zh) * 2019-09-30 2021-03-30 武汉大学 伊马替尼及其衍生物与镇痛药联合用药或复方制剂在治疗疼痛中的应用
CN114796448A (zh) * 2022-05-06 2022-07-29 延安大学 可乐定与Gap26在制备镇痛药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
JPH08139146A (ja) * 1994-11-14 1996-05-31 Shin Etsu Handotai Co Ltd 半導体表面のライフタイム評価方法
RU2180852C2 (ru) 1994-12-12 2002-03-27 Омерос Медикл Системс, Инк. Ингибирующий раствор и способ подавления боли, воспаления или спазма
US6673832B1 (en) * 1998-05-04 2004-01-06 Gudarz Davar Methods for identifying compounds for treating pain
EP1289558A2 (en) 2000-05-31 2003-03-12 Warner-Lambert Company Llc Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
US6573285B2 (en) * 2000-12-21 2003-06-03 Bristol-Myers Squibb Co. Method for preventing or treating pain by administering an endothelin antagonist
US20030232787A1 (en) * 2001-05-08 2003-12-18 Dooley David James Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic

Also Published As

Publication number Publication date
ECSP045153A (es) 2004-08-27
MXPA04005003A (es) 2004-08-11
JP2005513033A (ja) 2005-05-12
EA200400734A1 (ru) 2004-12-30
CA2464768A1 (en) 2003-06-05
US8114896B2 (en) 2012-02-14
WO2003045434A2 (en) 2003-06-05
EP1448233A2 (en) 2004-08-25
US7973064B2 (en) 2011-07-05
WO2003045434A3 (en) 2003-09-25
US8410148B2 (en) 2013-04-02
CO5590940A2 (es) 2005-12-30
ZA200403162B (en) 2005-01-26
US20100113396A1 (en) 2010-05-06
US20030100507A1 (en) 2003-05-29
CN1646166A (zh) 2005-07-27
US20100311665A1 (en) 2010-12-09
AU2002348224A1 (en) 2003-06-10
BR0214481A (pt) 2004-09-14
CA2464768C (en) 2009-12-29

Similar Documents

Publication Publication Date Title
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
DK1519770T3 (da) Elektroporesisk indretning og indsprøjtningsapparat
NO20011964L (no) Brönnbehandlingsfluider og fremgangsmåter for anvendelse derav
EP1296697A4 (en) Therapeutic agents - i
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
DE60202136D1 (de) Cache-eintrag-auswahlverfahren und -vorrichtung
NO20025227L (no) Tropanderivater nyttige i terapi
DE60132108D1 (de) Gefriergetrocknetes pantoprazol-präparat und pantoprazol-injektion
PT1326853E (pt) Novos tiadiazoles e oxadiazoles e sua utilizacao como inibidores da fosfodiesterase-7
DE50010609D1 (de) Sport-trainings-vorrichtung sowie sport-trainings-system
IS6661A (is) Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun
DE60113328T2 (de) Umreifungsmaschine
NO20015764L (no) Fremgangsmåte og preparat for å maskere mineralsmak
DE60142600D1 (de) Entwicklungsverfahren und -vorrichtung
DE60138239D1 (de) Plasmabehandlungsgerät
ATE297914T1 (de) Hydroxyphenyl-piperazinyl-methyl-benzamid- derivate zur schmerzbehandlung
DE60116488D1 (de) Fadenliefervorrichtung und -verfahren
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
NO20015951D0 (no) Höytrykks-saltvannskrystalliseringspunktanordning
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
NO20030593D0 (no) Fremgangsmåter for behandling av cancer og smerten forbundet derved ved å anvende endotelinantagonister
DE60022269D1 (de) Sprachbasiertes Manipulationsverfahren und -gerät
DE69929795D1 (de) Vorrichtung gegen überklettern
AT4056U3 (de) Therapie- und trainingsgerät

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application